These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3886403)

  • 1. Effect of oral slow-release terbutaline on early morning dyspnoea.
    Koëter GH; Postma DS; Keyzer JJ; Meurs H
    Eur J Clin Pharmacol; 1985; 28(2):159-62. PubMed ID: 3886403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the clinical and bronchodilating effects of plain and slow-release tablets of terbutaline at steady state.
    Pauwels R; Elinck W; Lamont H; van der Straeten M; Ljungholm K
    Br J Clin Pharmacol; 1986 Feb; 21(2):217-22. PubMed ID: 3513810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction.
    Postma DS; Koëter GH; Keyzer JJ; Meurs H
    J Allergy Clin Immunol; 1986 Mar; 77(3):471-7. PubMed ID: 3512664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction.
    Postma DS; Koëter GH; vd Mark TW; Reig RP; Sluiter HJ
    Chest; 1985 May; 87(5):653-7. PubMed ID: 3987377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbutaline sustained-release tablets in nocturnal asthma--a placebo-controlled comparison between a high and a low evening dose.
    Dahl R; Harving H; Säwedal L; Anehus S
    Br J Dis Chest; 1988 Jul; 82(3):237-41. PubMed ID: 3073803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nocturnal asthma: the role of sustained-release theophylline and oral beta-2-mimetics.
    Wilkens JH; Wilkens H; Heins M; Kurtin L; Oellerich M; Sybrecht GW
    Chronobiol Int; 1987; 4(3):387-96. PubMed ID: 3315268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbutaline slow-release tablets in children with asthma. A comparison with t.i.d. beta 2-agonist therapy.
    Croner S; Gustafsson M; Kjellman NI; Säwedal L
    Allergy; 1986 Jul; 41(5):331-4. PubMed ID: 2876658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.
    Heins M; Kurtin L; Oellerich M; Maes R; Sybrecht GW
    Eur Respir J; 1988 Apr; 1(4):306-10. PubMed ID: 3294036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbutaline slow-release tablets in children with bronchial asthma. Effect and pharmacokinetics compared with plain terbutaline tablets.
    Wettrell G; Anehus S; Hattevig G; Kjellman B
    Allergy; 1986 Aug; 41(6):418-22. PubMed ID: 3789327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbutaline controlled-release tablets and ipratropium aerosol in nocturnal asthma.
    Tammivaara R; Elo J; Mansury L
    Allergy; 1993 Jan; 48(1):45-8. PubMed ID: 8457025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
    Persson G; Gnosspelius Y; Anehus S
    Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbutaline depot tablets in asthma. A clinical evaluation.
    Taudorf E; Bundgaard A; Fagerström PO; Weeke E; Weeke B
    Allergy; 1981 Oct; 36(7):495-500. PubMed ID: 7039400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma.
    Stewart IC; Rhind GB; Power JT; Flenley DC; Douglas NJ
    Thorax; 1987 Oct; 42(10):797-800. PubMed ID: 3321540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily theophylline in the treatment of nocturnal asthma.
    Vilkka V; Brander P; Hakulinen A; Laitinen J; Sahlström K; Aalto E; Silvasti M; Karttunen P
    Eur J Clin Pharmacol; 1990; 39(3):241-3. PubMed ID: 2257859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction.
    McDonald CF; Pierce RJ; Thompson PJ; Allen D; Bowler S; Breslin AB; Bowes G; Saunders N; Murree-Allen K; Frith P; Musk AW
    J Asthma; 1997; 34(1):53-9. PubMed ID: 9033440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exercise-induced asthma in children and oral terbutaline. A dose-response relationship study].
    Hertz B; Fuglsang G; Holm EB
    Ugeskr Laeger; 1994 Sep; 156(39):5693-5. PubMed ID: 7985255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma.
    Eriksson NE; Haglind K; Ljungholm K
    Br J Dis Chest; 1982 Apr; 76(2):202-4. PubMed ID: 7046782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
    Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
    Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of terbutaline given in slow-release tablets.
    Nyberg L; Kennedy BM
    Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.